Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000864502 | SCV001005312 | likely benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002507483 | SCV002798814 | likely benign | Medulloblastoma; Familial dysautonomia | 2021-07-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004027624 | SCV003906989 | likely benign | not specified | 2023-02-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001830875 | SCV002082124 | likely benign | Familial dysautonomia | 2017-11-15 | no assertion criteria provided | clinical testing |